Palvella Therapeutics(PVLA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PVLA Palvella Therapeutics

交易中 07-10 13:20:49 EDT

25.81

+0.01

+0.04%

最高26.00	最低25.62	成交量2.55万
今开25.74	昨收25.80	日振幅1.49%
总市值2.85亿	流通市值1.48亿	总股本1,106万
成交额66.03万	换手率0.45%	流通股本573.06万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PVLA","market":"US","secType":"STK","nameCN":"Palvella Therapeutics","latestPrice":25.81,"timestamp":1752167737790,"preClose":25.8,"halted":0,"volume":25502,"delay":0,"floatShares":5730612,"shares":11055665,"eps":-5.045167,"marketStatus":"交易中","change":0.01,"latestTime":"07-10 13:20:49 EDT","open":25.74,"high":26,"low":25.615,"amount":660283.7323980001,"amplitude":0.014922,"askPrice":25.87,"askSize":100,"bidPrice":25.65,"bidSize":24,"shortable":3,"etf":0,"ttmEps":-5.045167,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1752177600000},"marketStatusCode":2,"adr":0,"listingDate":1435636800000,"exchange":"NASDAQ","adjPreClose":25.8,"postHourTrading":{"tag":"盘后","latestPrice":25.8,"preClose":25.8,"latestTime":"17:28 EDT","volume":368,"amount":9492,"timestamp":1752096498123},"volumeRatio":0.766398,"impliedVol":0.4556,"impliedVolPercentile":0.5625},"requestUrl":"/m/hq/s/PVLA","defaultTab":"news","newsList":[{"id":"2537715320","title":"Palvella Therapeutics, Inc.2025财年第一财季实现净利润-8.19百万美元，同比减少67.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537715320","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537715320?lang=zh_cn&edition=full","pubTime":"2025-05-24 00:00","pubTimestamp":1748016034,"startTime":"0","endTime":"0","summary":"5月24日，Palvella Therapeutics, Inc.公布财报，公告显示公司2025财年第一财季净利润为-8.19百万美元，同比减少67.48%；其中营业收入为0.00美元，每股基本收益为-0.74美元。机构评级：截至2025年5月24日，当前有9家机构对Palvella Therapeutics, Inc.目标价做出预测，其中目标均价为49.22美元，其中最低目标价为38.00美元，最高目标价为70.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524000100a6ea7cdb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524000100a6ea7cdb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PVLA","LENZ"],"gpt_icon":0},{"id":"2535397013","title":"加拿大投资银行集团：维持Palvella Therapeutics(PVLA.US)评级，由买入调整至买入评级, 目标价由53.00美元调整至52.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2535397013","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535397013?lang=zh_cn&edition=full","pubTime":"2025-05-16 20:51","pubTimestamp":1747399890,"startTime":"0","endTime":"0","summary":"加拿大投资银行集团：维持Palvella Therapeutics(PVLA.US)评级，由买入调整至买入评级, 目标价由53.00美元调整至52.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/16205150462712.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","PVLA"],"gpt_icon":0},{"id":"2509407655","title":"Palvella Therapeutics(PVLA.US)获TD Cowen首次覆盖，给予买入评级, 目标价44.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2509407655","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509407655?lang=zh_cn&edition=full","pubTime":"2025-02-05 20:11","pubTimestamp":1738757515,"startTime":"0","endTime":"0","summary":"Palvella Therapeutics(PVLA.US)获TD Cowen首次覆盖，给予买入评级, 目标价44.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/05201147968471.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["TD","PVLA","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pieris.com","stockEarnings":[{"period":"1week","weight":0.0829},{"period":"1month","weight":-0.0312},{"period":"3month","weight":0.2984},{"period":"6month","weight":0.8468},{"period":"1year","weight":2.4538},{"period":"ytd","weight":1.15}],"compareEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.1896},{"period":"6month","weight":0.0751},{"period":"1year","weight":0.1228},{"period":"ytd","weight":0.0648}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Palvella Therapeutics, Inc.在内华达的法律下成立于2013年5月24日。该公司是一家生物技术公司，历史上发现并开发了基于Anticalin蛋白的药物，以独特和变革性的方式靶向已验证的疾病途径。2024年3月27日，公司实施了措施，以最大限度地提高其从其合作候选药物临床管道收集潜在里程碑的能力，并保持其考虑其他战略选择的能力。该公司的临床管线包括与合作者合作的免疫肿瘤学或IO双特异性药物，包括靶向PD-L1和4-1BB的S095012（也称PRS-344）、靶向CD228和4-1BB的SGN-BB228（也称PRS-346）以及靶向GPC3和4-1BB的BOS-342（也称PRS-342）。Anticalin蛋白是公司专有的，是一类新型疗法，已在临床上通过与领先制药公司的合作关系得到验证。","yearOnYearQuotes":[{"month":1,"riseRate":0.7,"avgChangeRate":0.102904},{"month":2,"riseRate":0.5,"avgChangeRate":0.02179},{"month":3,"riseRate":0.5,"avgChangeRate":0.012293},{"month":4,"riseRate":0.2,"avgChangeRate":-0.082116},{"month":5,"riseRate":0.5,"avgChangeRate":0.168212},{"month":6,"riseRate":0.4,"avgChangeRate":-0.088952},{"month":7,"riseRate":0.727273,"avgChangeRate":0.126214},{"month":8,"riseRate":0.6,"avgChangeRate":0.081761},{"month":9,"riseRate":0.3,"avgChangeRate":-0.115283},{"month":10,"riseRate":0.2,"avgChangeRate":-0.082714},{"month":11,"riseRate":0.5,"avgChangeRate":0.04477},{"month":12,"riseRate":0.3,"avgChangeRate":-0.058257}],"exchange":"NASDAQ","name":"Palvella Therapeutics","nameEN":"Palvella Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Palvella Therapeutics(PVLA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Palvella Therapeutics(PVLA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Palvella Therapeutics,PVLA,Palvella Therapeutics股票,Palvella Therapeutics股票老虎,Palvella Therapeutics股票老虎国际,Palvella Therapeutics行情,Palvella Therapeutics股票行情,Palvella Therapeutics股价,Palvella Therapeutics股市,Palvella Therapeutics股票价格,Palvella Therapeutics股票交易,Palvella Therapeutics股票购买,Palvella Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Palvella Therapeutics(PVLA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Palvella Therapeutics(PVLA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}